High Dose GcMAF 2.5 ml multi-dose vials (1500 ng/0.5 ml):
Each vial contains 4 doses GcMAF at 0.5 ml/dose with 0.5 ml extra GcMAF per vial. Up to 5 doses GcMAF may be possible to use for each vial.
Minimum order of 4 vials.
Common quantities - 4, 6, 8, 10 and 12 vials. Other quantities available.
Please contact us for pricing.
Prices quoted usually cost 9,000 JPY for shipping and handling by EMS International Express Mail Service worldwide (unless specified otherwise). Cost of shipping by UPS, FedEx, DHL or other shipping companies may need to be calculated for some countries.
All GcMAF is manufactured to our patented Second Generation GcMAF production process.
Keep vials refrigerated at 2-8 °C for multi-dose use. For long term storage > 1 year, vials maybe be kept frozen and defrosted once for multi-dose use.
Please contact us if you require other quantities.
By ordering you are considered a patient of Saisei Mirai Clinics. Any personal information provided is treated as confidential.
Payment is by wire transfer to our account in Japan. After you confirm your order with us, simply make your wire transfer (see details below). Ideally funds should be sent as Japanese Yen (JPY) or the foreign currency equivalent amount (such as USD or EUR) calculated by your bank, and accept all fees and charges, so that the correct amount is received by us. Once you have made your transfer, please let us know the details of the transfer (such as the account name and bank), and also the products and quantities you are ordering. As soon as we confirm your payment, we will ship your Gc-MAF on the next suitable day depending on the destination. Allow 2-3 business days for payments to be cleared and received by us. If you do not hear anything from us within 7 days, please contact us with details of your payment and order information.
Wire transfer details (International Telegraphic Transfer):
Beneficiary: Saiseimirai Med. Corp.
Beneficiary address: 3-34-8 Okubo-cho, Moriguchi-shi, Osaka 570-0012, Japan
Name of bank: Sumitomo Mitsui Banking Corporation, Neyagawa Branch
Bank Address: 16-14 Hayako-cho, Neyagawa-shi, Osaka 572-0837, Japan
Account number: 7092026
SWIFT: SMBCJPJT (or BIC: SMBCJPJTXXX)
Visit your bank and ask the staff to make a wire transfer from your account. Alternatively, you may be able to do this online via your bank's internet banking service, if you have this set up.
Funds should be sent as Japanese Yen (JPY).
Note: International Bank Account Number (IBAN) is not used in Japan.
Internet banking: Some websites don't allow a dash to be included in the postal code, so if necessary, the dash may be omitted so that the post code/ZIP code becomes one number (e.g., 570-0012 becomes 5700012).
Please ensure you provide us with your full name, shipping address and a contact telephone number when you order.
GcMAF is a natural immunotherapy product. Variation in GcMAF concentration is due to normal variation between serum samples. Just like Lymphocytes or Natural Killer cells vary in number between people and at any given time, so will the amount of GcMAF which can be produced.
Charges for shipping and handling apply to each order. We use EMS International Express Mail Service with tracking information. Each package includes cooling packs to keep Gc-MAF at a stable temperature during shipping. Our second generation GcMAF is strong enough at room temperature to maintain a high level of activity for the days in transit. See more details about the Stability of GcMAF in Serum (PDF) report in Research and references for an experiment done by the University of Tokushima on stability by phagocytic activity of our 2nd generation GcMAF after short-term and long-term storage.
We ship GcMAF as a liquid in high quality multi-dose vials. After arrival the vials should be stored in the refrigerator to maintain maximum activity until each injection.
Activity remains stable at room temperature for a minimum of 2 weeks and at least 1 year refrigerated (2-8 °C).
We use special packaging and cooling packs to keep the temperature of the vials stable. GcMAF is strong enough at room temperature to maintain a high level of activity for the days in transit. See Tests of our GcMAF and Research and references for more details. The GcMAF is expected to reach you in excellent condition with no loss in activity. We ship fresh Gc-MAF as a liquid. After arrival the vials containing GcMAF should be stored refrigerated to maintain maximum activity for multi-dose use.
If you wish to purchase GcMAF therapy or make an enquiry, please contact us with details of your disease, current treatment and the quantities of Gc-MAF you require.
We are very pleased to announce we now have an Instagram account!
You can find us at @saiseimirai or simply click here to view our feed on the web . We promise to post news about Saisei Mirai and GcMAF every day, so that you are aware of all the news as well as the success of our patients.
Seminar, at Arbetets Museum, Norrkoping,Sweden, May 29
Thank you Sweden, for your kindness and warm welcome!
Dr.Toshio Inui and Dr Kentaro Kubo gave prsentation about clinical use of GcMAF (+ Oral Colostrum MAF), and Skin cell injection therapy in Norrkoping, Sweden on May 29, 2018.
2018 Integrative Medical Conference－ Vilnius, Lithuania.
Thank you very much for your participation at the Saisei Mirai 2018 Integrative Medical Conference in Lithuania, held on Saturday 26 May 2018.
We hope that you found the conference informative and worthwhile.
Your presence helped to make this event a great success and your enthusiasm and positive spirit helped make our time together both productive and fun.
We wish you all the best and hope that you continue to be with the the Saisei Mirai.
Saisei Mirai X-MAF Series activate Macrophage.
Saisei Mirai Colostrum MAF has been in development for more than 10 years.
→ Saisei Pharma
Dr. Shinichiro Akiyama held seminars for Doctors and Patients in Tifana, Mexico on Apr 09, 11, 2018.
Dr. Antonio Jimenez, Chief Medical Officer of Hope4Cancer Treatment Centers, presents "The Importance of Emotions in Cancer" at a conference in Beaumont, Texas (Jan 2018).
Dr. Antonio Jimenez presenting at the “Un Mundo Sin Cancer” (“A World Without Cancer”) conference in Barcelona, Spain (Jan 2018).
Dr. Antonio Jimenez being interviewed in the Fox News Morning Show at Beaumont, Texas (Jan 2018).
Dr.Toshio Inui gave a presentation 「QSS JAPAN TEAM Year End Seminar」 in Tokyo, Japan on Dec 23, 2017.
Dr. Toshio Inui gave presentation in Faculty of Medicine of Vilnius University in Lithuania on Nov 30, 2017. He introduced Saisei Mirai Clinic and therapy methods available at Saisei Mirai Clinic in Japan.
Dr. Toshio Inui gave presentation in Vilnius University Hospital Santaros Klinikos in Lithuania, on Nov 29, 2017. He introduced Saisei Mirai Clinic and therapy methods available at Saisei Mirai Clinic in Japan.
2017 Integrative Medical Therapies Conference - Osaka, Japan
Symposium on Integrated Medicine: Electric Fields Therapy & Immunotherapy - Jakarta, Indonesia
Dr. Toshio Inui gave a presentation of the electric field therapy and second-generation GcMAF and colostrum MAF at a conference which was held in Jakarta, Indonesia on July 22, 2016.
International Pharmacy Conference
14 to 15-JUL-2016
Dr. Shinichiro Akiyama at International Pharmacy Conference, which was held in the United States Philadelphia, Pennsylvania on July 14 to 15, 2016, the Clinical experience of colostrum derived protein against solid cancer has been announced as the Keynote Speaker.
New research papers published by Saisei Mirai in Anticancer Research available online.
New research papers published by Saisei Mirai in Anticancer Research available online.
New research papers on GcMAF and integrative cancer immunotherapy treatment written in collaboration with the University of Tokushima, Kanazawa University and Kobe University Graduate School of Medicine researchers and Saisei Mirai published in Anticancer Research journal.
Experiment report of Gc MAF stability assay
14-JUN-2012 Stability of GcMAF in Serum (PDF)
H Mukai, Y Uto. Department of Biological Science and Technology, The University of Tokushima.
The results show that 2nd Generation GcMAF is stable for 1 year at 4 °C, for 14 days at room temperature (around 20 °C), and for 7 days at 40 °C.
See Research and references for more details on experiments on macrophage phagocytic activity and stability of our GcMAF.
Collaborations with the University of Tokushima
We collaborate with GcMAF researchers at the University of Tokushima, Japan in the development of second generation GcMAF. See Research and references for published research papers on Gc-MAF in peer-reviewed scientific journals authored by the University of Tokushima researchers over the last decade. Our research on GcMAF is ongoing and papers are being prepared for publication in collaboration between the University of Tokushima and Saisei Mirai in the next few months.